Print Page

给 医 护 专 业 人 员 的 信
 
Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months in the United Kingdom, including additional oversight on initiation of treatment for patients under 18 years (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years (English only)  
Related Information:
Australia: New safety warnings for isotretinoin (Roaccutane) (English only) 上载于 2025-04-08
Canada: Summary Safety Review: Isotretinoin: Assessing the potential risk of sex... 上载于 2024-07-26
Singapore: HSA: Isotretinoin and risk of psychiatric disorders and sexual dysfun... 上载于 2023-12-16
The United Kingdom: Isotretinoin (Roaccutane▼): introduction of new safety measu... 上载于 2023-11-01
The United Kingdom: Isotretinoin (Roaccutane▼): new safety measures to be introd... 上载于 2023-04-27
The United Kingdom: Isotretinoin: an expert review of suspected psychiatric and ... 上载于 2020-11-11
The United Kingdom: Isotretinoin (Roaccutane▼): reminder of important risks and ... 上载于 2020-08-27
英国：异维A酸(Roaccutane)：勃起功能障碍及性欲减少的罕有报告 上载于 2017-10-27
Isotretinoin (Roaccutane): rare reports of erectile dysfunction and decreased li... 上载于 2017-10-27
加拿大：加拿大卫生局强调服用粉刺药物异维A酸期间预防怀孕的重要性，以避免出生缺陷 上载于 2016-09-08
 
back